.On the heels of a $3 billion fund coming from Bain Funding Life Sciences, Arch Project Partners is ...
.Finnish biotech Orion has spied potential in Aitia's "electronic twin" tech to develop brand-new ca...
.While Windtree Therapies has actually struggled to increase the financial origins required to survi...
.OncoC4 is actually taking AcroImmune-- as well as its own in-house medical production functionaliti...
.Amgen has actually discussed (PDF) the initial phase 3 data on its $400 million dermatitis medicine...
.Biogen and also UCB's bet one's bottom dollar advancing right into phase 3 astride a failed study t...
.Italian biotech Aptadir Therapies has released with the assurance that its own pipeline of preclini...
.Surge Lifestyle Sciences has met its objective in a Duchenne muscle dystrophy (DMD) research study,...
.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma crease, occup...
.Achilles Therapies has shreded its technique. The British biotech is stopping work on its clinical-...